Short answer · Medically reviewed summary · Last updated: 2026-04-07
The primary cause of Waldenstrom Macroglobulinemia is a somatic mutation in the MYD88 gene, which leads to the uncontrolled growth of abnormal B-lymphocytes that secrete excessive amounts of IgM protein. Understanding the Genetic Drivers In the vast majority of patients—approximately 90% to 95%—Waldenstrom Macroglobulinemia is characterized by a specific mutation in the MYD88 gene (specifically the L265P mutation). Think of the MYD88 gene as a cellular "on/off" switch; in this disease, the switch becomes stuck in the "on" position, sending constant signals for the cells to multiply and produce excess IgM antibodies.
Which are the causes of Waldenstrom Macroglobulinemia?
Causes of Waldenstrom Macroglobulinemia explained: genetic and environmental factors, reviewed against medical sources, plus patient perspectives.
The primary cause of Waldenstrom Macroglobulinemia is a somatic mutation in the MYD88 gene, which leads to the uncontrolled growth of abnormal B-lymphocytes that secrete excessive amounts of IgM protein.
Understanding the Genetic Drivers
In the vast majority of patients—approximately 90% to 95%—Waldenstrom Macroglobulinemia is characterized by a specific mutation in the MYD88 gene (specifically the L265P mutation). Think of the MYD88 gene as a cellular "on/off" switch; in this disease, the switch becomes stuck in the "on" position, sending constant signals for the cells to multiply and produce excess IgM antibodies. Additionally, a significant portion of patients exhibit mutations in the CXCR4 gene, which can influence how the disease behaves and responds to certain therapies. Because these mutations are "somatic," they are acquired during a person's lifetime rather than inherited from parents; they occur in the bone marrow cells, not the germline.
Risk Factors vs. Causes
It is important to distinguish between a cause and a risk factor. A cause is the biological mechanism (the mutation) that directly triggers the disease. A risk factor is a statistical association that may increase the likelihood of developing the condition. While the exact etiology of why these mutations occur remains a subject of intense research, we know that Waldenstrom Macroglobulinemia is not caused by lifestyle choices. Some research suggests that chronic immune stimulation or a history of monoclonal gammopathy of undetermined significance (MGUS) may act as precursors or risk factors for developing Waldenstrom Macroglobulinemia.
Current Research and Etiology
While we have identified the "driver" mutations, researchers are currently investigating why these specific mutations arise and how the bone marrow microenvironment supports the survival of these malignant cells. By studying the inflammatory pathways activated by MYD88, scientists are developing more targeted therapies to "turn off" the abnormal signaling. Understanding the molecular landscape of Waldenstrom Macroglobulinemia is the cornerstone of modern clinical research, moving us closer to personalized treatment strategies that address the root cause rather than just the symptoms.
Medical Disclaimer: This information is for educational purposes and does not constitute medical advice, diagnosis, or treatment. Always seek the advice of your physician or other qualified health provider with any questions you may have regarding a medical condition.
References
- NIH Genetic and Rare Diseases Information Center (GARD)
- Orphanet: The portal for rare diseases and orphan drugs
- International Waldenström’s Macroglobulinemia Foundation (IWMF)
- OMIM (Online Mendelian Inheritance in Man)
